Pulsion targets US for growth
This article was originally published in Clinica
Executive Summary
German company Pulsion Medical Systems, which makes diagnostic, monitoring and treatment management systems, is to increase its share capital by E786,900 ($780,290) to E8.7m in order to fund an expansion of international sales. "We will use the new capital to see our three innovative products through into markets around the world even faster, with special attention to the most exciting market for Pulsion, the US," said CEO Dr Ulrich Pfeiffer. The company has concrete plans for expansion in the US, but has no specific details for growth in any other country at present, a spokesperson told Clinica.